Hyderabad’s AIG Hospitals announce results of monoclonal antibody therapy for COVID-19
The Hindu
The cocktail drug consists of Casirivimab 600, Imdevimab 600
The effectiveness of a cocktail drug that helped prevent the progression of mild, moderate form COVID into severe form was announced in Hyderabad, Telangana, on Tuesday.
Monoclonal antibody therapy helps prevent severe COVID and deaths 100%, as per AIG Hospitals study. The cocktail consists of Casirivimab 600, Imdevimab 600.
More Related News